Imagine a career in a field you can’t imagine. Dominique Constantini parlayed her commitment to immunology to meeting unmet ...

Oklahoma Cancer Specialists and Research Institute has partnered with a non-profit oncology research organization, granting ...

Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, today announced plans to launch its validated ...

Prostate cancer presents challenges in detection, treatment, and management. Learn about genetic risks, treatment resistance, ...

Argon Medical, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional ...

CEO Albert Bourla expressed modest optimism for Pfizer’s 2025 revenues at JPM 2025, supported by plans to prioritize R&D in ...

ALX Oncology Holdings Inc. (NASDAQ:ALXO), a biopharmaceutical company currently valued at $93.36 million, has announced the adoption of a new equity incentive plan, effective January 16, 2025. The ...

Ancestry-based differences in frequencies of biomarkers that drive patient selection for treatment with precision oncology ...

At my routine oncology checkup, I regretted not bringing my husband when an unexpected medication changes left me feeling ...

Elevation Oncology Inc (ELEV) stock saw a decline, ending the day at $0.73 which represents a decrease of $-0.05 or -6.41% from the prior close of $0.78. The stock opened at $0.78 and touched a low of ...

The University of Kentucky Albert B. Chandler Hospital is one of the nation’s top “Hospitals and Health Systems with Great ...

JP Morgan attendees were told of Jazz Pharmaceuticals' plans to expand indications for two oncology drugs: zanidatamab and ...